Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Nonlinear Pharmacokinetics: Michaelis-Menten Equation01:18

Nonlinear Pharmacokinetics: Michaelis-Menten Equation

995
The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
995
Enzyme Inhibition01:30

Enzyme Inhibition

91.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Determination of Michaelis Constant and Maximum Elimination Rate01:20

Determination of Michaelis Constant and Maximum Elimination Rate

418
The Michaelis constant (KM) and the theoretical maximum process rate (Vmax) are vital parameters in the Michaelis-Menten equation, central to many biochemical reactions. They provide essential insights into enzyme kinetics and drug metabolism.
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
418
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

6.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.3K
Feedback Inhibition00:46

Feedback Inhibition

56.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.

SLAS discovery : advancing life sciences R & D·2026
Same author

Phosphoinositides and inositol phosphates as molecular glues.

FEBS letters·2026
Same author

Structure-guided compound prioritization strategy for virtual screening identifies putative binders for the nuclear receptor LRH-1.

bioRxiv : the preprint server for biology·2026
Same author

Structural insights into the development of inhibitors for inositol phosphate kinases.

FEBS letters·2026
Same author

Structural rationalization of IPMK inhibitor potency.

bioRxiv : the preprint server for biology·2025
Same author

VisMoDAI: Visual Analytics for Evaluating and Improving Corruption Robustness of Vision-Language Models.

IEEE transactions on visualization and computer graphics·2025

相关实验视频

Updated: Jan 11, 2026

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

7.1K

IPMK 抑制剂功率的结构合理化

Huanchen Wang1, Stephen B Shears1, Raymond D Blind2,3

  • 1Molecular and Cellular Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709, United States.

Journal of medicinal chemistry
|November 14, 2025
PubMed
概括
此摘要是机器生成的。

对强大的内醇聚酸多激酶 (IPMK) 抑制剂的结构洞察力揭示了ATP结合部位内的关键相互作用. 这项研究提供了14种新的结构,以指导未来的癌症药物开发,以IPMK为目标.

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.8K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.5K

相关实验视频

Last Updated: Jan 11, 2026

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

7.1K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.8K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.5K

科学领域:

  • 生物化学 生物化学
  • 结构生物学 结构生物学
  • 药用化学 医学化学

背景情况:

  • 伊诺西聚酸盐多酶 (IPMK) 与各种癌症有关.
  • 用ATP竞争性抑制剂向IPMK显示出癌症治疗的前景.
  • 强大的IPMK抑制的结构基础在很大程度上仍未被探索.

研究的目的:

  • 阐明新型IPMK抑制剂高强度背后的结构机制.
  • 为未来的IPMK抑制剂设计提供全面的结构参考.
  • 了解驱动抑制剂选择性和有效性的分子相互作用.

主要方法:

  • 进行X射线晶体学以确定人类IPMK激酶域的14种新型共晶结构.
  • 放射性标记测试用于IC50的确定.
  • 异热定位热量计用于KD值的确定.

主要成果:

  • 人类IPMK与14种不同的抑制剂结合的详细原子分辨率结构.
  • 在ATP结合部位内确定一个特定的口袋,这对于高强度抑制剂结合至关重要.
  • 观察了两个有序的水分子,它们与强大的抑制剂一起对结网络做出了贡献.

结论:

  • 这项研究为新型IPMK抑制剂的效力和选择性提供了分子基础.
  • 14种新的抑制剂结合的IPMK结构是未来基于结构的药物发现工作的宝贵资源.
  • 这项工作通过阐明IPMK抑制剂相互作用,推动了向癌症治疗的发展.